 |
|
 |
 |

Home > Company Index > Chemicals > Diversified Chemicals > Cambrex Corporation
 |
Cambrex Corporation |
 |
 |
 |
PROFILE |
 |
Through its subsidiaries, Cambrex operates in four segments: human health, specialty and fine chemicals, biosciences, and animal health and agriculture. The human health segment (47% of sales) makes active pharmaceutical ingredients for over-the-counter and prescription drugs, and intermediates used in cosmetics and food additives. The specialty chemicals unit (25%) provides performance-enhancing chemicals and polymer systems. The biosciences segment makes cell culture products, endotoxin detection products, and electrophoresis and chromatography products. The animal health and agriculture unit produces Vitamin B-3 for feed additives, health products for disease prevention, and intermediates for crop protection.
COMPETITION |
 |
The Dow Chemical Company (DOW)
E. I. du Pont de Nemours and Company (DD)
Pharmacia Corporation (PHA)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 484.20
1-Yr. Sales Growth: 0.6%
Employees: 1,852
Revenue per employee: $261,447.08
KEY PEOPLE |
 |
James A. Mack
CEO
Salvatore J. Guccione
CFO
CONTACT INFO |
 |
1 Meadowlands Plaza
East Rutherford, NJ 07073
US
Phone: 201-804-3000
Fax: 201-804-9852
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |